We are live on ! Find out more
CA

Clearstead Advisors Portfolio holdings

AUM $10.9B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+7.18%
1 Year Est. Return
+18.41%
3 Year Est. Return
+59.5%
5 Year Est. Return
+69.09%
10 Year Est. Return
AUM
$7.62B
AUM Growth
+$501M
Cap. Flow
-$682M
Cap. Flow %
-8.96%
Top 10 Hldgs %
31.49%
Holding
3,289
New
550
Increased
1,163
Reduced
866
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 12.31%
2 Financials 6.67%
3 Industrials 4.87%
4 Consumer Discretionary 3.57%
5 Healthcare 3.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABCB icon
851
Ameris Bancorp
ABCB
$5.89B
$226K ﹤0.01%
3,082
+2,983
+3,013% +$210K
SCHE icon
852
Schwab Emerging Markets Equity ETF
SCHE
$12.3B
$226K ﹤0.01%
6,770
-1,628
-19% -$51.3K
ZSEP
853
Innovator Equity Defined Protection ETF - 1 Yr September
ZSEP
$124M
$225K ﹤0.01%
8,495
BSCV icon
854
Invesco BulletShares 2031 Corporate Bond ETF
BSCV
$1.75B
$224K ﹤0.01%
13,439
COIN icon
855
Coinbase
COIN
$41.7B
$223K ﹤0.01%
660
-193
-23% -$65.4K
SLYV icon
856
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.89B
$223K ﹤0.01%
2,510
DFIN icon
857
Donnelley Financial Solutions
DFIN
$1.21B
$221K ﹤0.01%
+4,300
New +$245K
GSIE icon
858
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$5.86B
$221K ﹤0.01%
5,371
+2
+0% +$81
HLN icon
859
Haleon
HLN
$43.1B
$219K ﹤0.01%
24,441
-1,129
-4% -$10.9K
HUBS icon
860
HubSpot
HUBS
$10.5B
$218K ﹤0.01%
467
+84
+22% +$42.3K
XHB icon
861
State Street SPDR S&P Homebuilders ETF
XHB
$1.74B
$218K ﹤0.01%
1,968
+103
+6% +$11.3K
DVA icon
862
DaVita
DVA
$15.1B
$218K ﹤0.01%
1,640
-11
-0.7% -$1.51K
SNDK
863
Sandisk
SNDK
$213B
$216K ﹤0.01%
1,927
+550
+40% +$32.1K
PEG icon
864
Public Service Enterprise Group
PEG
$39.8B
$216K ﹤0.01%
2,584
+43
+2% +$3.61K
AMRZ
865
Amrize Ltd
AMRZ
$27.3B
$215K ﹤0.01%
+4,424
New +$226K
DGX icon
866
Quest Diagnostics
DGX
$25.1B
$213K ﹤0.01%
1,119
-1,314
-54% -$233K
ARM icon
867
Arm
ARM
$278B
$213K ﹤0.01%
1,506
-238
-14% -$34.7K
FBT icon
868
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.8B
$211K ﹤0.01%
1,179
ZBRA icon
869
Zebra Technologies
ZBRA
$12.4B
$211K ﹤0.01%
710
+19
+3% +$6.07K
BIIB icon
870
Biogen
BIIB
$29.9B
$210K ﹤0.01%
1,502
-181
-11% -$24.5K
IWY icon
871
iShares Russell Top 200 Growth ETF
IWY
$16B
$209K ﹤0.01%
+764
New +$198K
RWL icon
872
Invesco S&P 500 Revenue ETF
RWL
$9.51B
$206K ﹤0.01%
1,866
-94
-5% -$10K
BSCP
873
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
$206K ﹤0.01%
9,965
-5,596
-36% -$116K
TER icon
874
Teradyne
TER
$54.8B
$206K ﹤0.01%
1,497
-18
-1% -$1.97K
NNBR icon
875
NN Inc
NNBR
$272M
$206K ﹤0.01%
100,000

Similar funds

Clearstead Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Clearstead Advisors held 3,289 positions worth $7.62B, up 7% from $7.12B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Clearstead Advisors withdrew a net $682M in Q3 2025, closing 207 positions and reducing 866 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $694M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Industrials.

Against the trend, Clearstead Advisors opened a new position in Invesco BulletShares 2033 Corporate Bond ETF worth $20.4M.

  • Clearstead Advisors's largest Q3 2025 buy was Invesco BulletShares 2033 Corporate Bond ETF: 949,887 shares worth $20.4M.
  • Clearstead Advisors added most to iShares Core MSCI Total International Stock ETF in Q3 2025, an estimated $22.8M increase.
  • Clearstead Advisors's biggest Q3 2025 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $21.4M.
  • Clearstead Advisors fully exited Vanguard S&P 500 ETF in Q3 2025, selling an estimated $694M.
  • Clearstead Advisors's ten largest holdings make up 31% of its $7.62B portfolio in Q3 2025.
  • Clearstead Advisors opened 550 new positions and closed 207 in Q3 2025.
  • Clearstead Advisors's portfolio value rose 7% quarter-over-quarter to $7.62B.

Based on Clearstead Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.